logo
logo

Lung cancer clinical trial elig criteria & requirements increased in number and complexity

avatar
Isiah Jone
Aug 10, 2017 16:05
img

DENVER -Eligibility criteria continue to increase in number and complexity for lung cancer clinical trials.

Cancer clinical trials have complex requirements for design, study, and eligibility criteria that often act as a barrier to the development of new clinical trials as well as patient enrollment.

With the advent of molecular targeted therapies and immunotherapy, requirement criteria have continued to increase in number and complexity.

Despite calls to streamline cancer clinical trial processes and efforts to improve cancer clinical trial patient accrual, completion rates and generalizability, fewer than two percent of adults with cancer in the United States participate in clinical trials.

A group of investigators in the United States conducted a retrospective study to evaluate contemporary trends in cancer clinical trial inclusiveness and complexity.

The group quantified and categorized eligibility criteria in lung cancer clinical trials sponsored or endorsed by the Eastern Cooperative Oncology Group (ECOG) Thoracic Committee from 1986 through 2016.

collect
0
avatar
Isiah Jone
Aug 10, 2017 16:05
guide
Zupyak is a free content platform for publishing and discovering stories, software and startups.